[1]
A. Sarici, “Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience”, annalsmedres, vol. 28, no. 11, pp. 2065–2070, Nov. 2021.